Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.
Przespolewski A, Goldberg AD, Talati C, Fazal S, Vachhani P, Sanikommu SR, Thota S, Waksal J, Ball B, Famulare C, Stahl M, Baron J, Griffiths EA, Thompson JE, Sweet K, Wang ES.
Przespolewski A, et al. Among authors: fazal s.
Blood. 2023 Mar 23;141(12):1489-1493. doi: 10.1182/blood.2022016678.
Blood. 2023.
PMID: 36493344
Free article.
No abstract available.